CHI’s 7th Annual Immuno-Oncology Summit Europe

Alloplex CEO, Dr. Frank Borriello is a speaker within the Gamma Delta Immunotherapy Track.

Topic:

• SUPLEXA Platform for Reprogramming Immune Cells for the Treatment of Cancer.

https://www.immuno-oncologyeurope.com/